NDMA & NDEA: What’s the Difference?

In July 2018, the FDA recalled certain batches of valsartan after investigators found N-Nitrosimethylamine (NDMA) had contaminated the drug. Since then, several batches of valsartan, irbesartan, and losartan have been recalled due to NDMA and N-Nitrosodiethylamine (NDEA) contamination. These nitrosamines are classified as probable human carcinogens.

How Are They Similar?

NDMA and NDEA are both classified by the Environmental Protection Agency as probable human carcinogens. Exposure to these carcinogens can cause tumors to develop in the respiratory tract. Specifically, an individual may develop liver, kidney, stomach, colorectal, and/or intestinal cancer.

What’s the Difference?

The main difference between NDMA and NDEA is toxicity. NDEA happens to be about three times more toxic than NDMA.

What Should I Do?

If you or a loved one took a recalled valsartan, irbesartan, or losartan and developed liver, kidney, stomach, colorectal, or intestinal cancer, please fill out the form below. We deliver the Gold standard advocacy you deserve.

New Carcinogen Found in Losartan

On February 28, 2019, the FDA recalled 87 lots of losartan after finding trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA). NMBA is the third nitrosamine found in the angiotensin II receptor blocker (ARB) medicines valsartan, losartan, and irbesartan.  NDMA and NDEA, two other nitrosamines, were previously found in these drugs leading to numerous recalls.

Like NDMA and NDEA, NMBA is considered a probable human carcinogen. The FDA has concluded that the levels of NMBA found in the recalled lots are higher than the FDA’s interim acceptable intake limits. The nitrosamines found in the ARB medications can cause numerous types of cancer including liver cancer, kidney cancer, stomach cancer, and colorectal cancer.

The most recent recall includes lots from Camber Pharmaceuticals, Inc. The full list of recalled products can be found on the FDA’s website. If you or a loved one took a recalled product, contact your doctor before you stop taking the product.

GoldenbergLaw is currently accepting valsartan, irbesartan, and losartan cases in which an individual was diagnosed with liver, kidney, colorectal, or stomach cancer. Contact us for a free case consultation.

Johnson & Johnson Subpoenaed Over Baby Powder Concerns

On Wednesday, February 20, Johnson & Johnson revealed that the company received subpoenas from the U.S. Justice Department and the Securities and Exchange Commission (SEC). The subpoenas are related to the litigation regarding alleged asbestos contamination in J&J’s baby powder.

Johnson & Johnson has said it will “cooperate fully with these inquiries and will continue to defend the Company in the talc-related litigation.”

This follows a Reuters report from December 2018 that stated Johnson & Johnson knew its talcum powder contained asbestos. On that day, J&J’s shares dropped significantly, losing $40 billion in market value.

J&J shares fell another 2.1{73438c93b9a6e6bfc5cd31bf6578637c675720219417f2f1a65e7c8e6c24cfa4} after news broke that it was being subpoenaed.

Contact GoldenbergLaw if you or a loved one was diagnosed with ovarian cancer or mesothelioma after years of extensive talcum powder use. We deliver the Gold standard advocacy you deserve.